MPW
NVO

MASECO Private Wealth’s Novo Nordisk NVO Stock Holding History

MASECO Private Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3K Sell
471
-103
-18% -$4.88K ﹤0.01% 202
2025
Q4 		$29.2K Buy
+574
New +$29.4K ﹤0.01% 221
2025
Q3 		– Sell
-570
Closed -$39.3K – 436
2025
Q2 		$39.3K Buy
+570
New +$38.8K ﹤0.01% 187

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

MASECO Private Wealth's NVO Position: Q1 2026 in Review

MASECO Private Wealth reduced its Novo Nordisk (NVO) stake by 18% in Q1 2026, selling an estimated $4.88K and leaving 471 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #202.

MASECO Private Wealth first reported a position in NVO in Q2 2025 and has held it in 3 quarters since. The position peaked at $39.3K in Q2 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • MASECO Private Wealth held 471 shares of Novo Nordisk worth $17.3K as of Q1 2026.
  • MASECO Private Wealth sold 103 Novo Nordisk shares in Q1 2026, an estimated $4.88K.
  • Novo Nordisk made up ﹤0.01% of MASECO Private Wealth's portfolio in Q1 2026, its #202 holding.
  • MASECO Private Wealth first reported a position in Novo Nordisk in Q2 2025 and has held it in 3 quarters since.
  • MASECO Private Wealth's Novo Nordisk position peaked at $39.3K in Q2 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on MASECO Private Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.